16100469|t|Delirium and extrapyramidal symptoms due to a lithium-olanzapine combination therapy: a case report.
16100469|a|We report an elderly patient who developed severe delirium and extrapyramidal signs after initiation of lithium-olanzapine combination. On hospital admission, serum levels of lithium were found to be 3.0 mM/L which were far above toxic level. Immediate discontinuation of both drugs resulted in complete resolution of most of the symptoms except for perioral dyskinesia which persisted for three more months. We critically discussed the differential diagnosis of lithium intoxication and assessed confounding factors which induce delirium and extrapyramidal signs related with combination therapy of lithium and olanzapine.
16100469	0	8	Delirium	Disease	MESH:D003693
16100469	13	36	extrapyramidal symptoms	Disease	MESH:D001480
16100469	46	53	lithium	Chemical	MESH:D008094
16100469	54	64	olanzapine	Chemical	MESH:D000077152
16100469	122	129	patient	Species	9606
16100469	151	159	delirium	Disease	MESH:D003693
16100469	164	184	extrapyramidal signs	Disease	MESH:D001480
16100469	205	212	lithium	Chemical	MESH:D008094
16100469	213	223	olanzapine	Chemical	MESH:D000077152
16100469	276	283	lithium	Chemical	MESH:D008094
16100469	451	470	perioral dyskinesia	Disease	MESH:D004409
16100469	564	571	lithium	Chemical	MESH:D008094
16100469	631	639	delirium	Disease	MESH:D003693
16100469	644	664	extrapyramidal signs	Disease	MESH:D001480
16100469	701	708	lithium	Chemical	MESH:D008094
16100469	713	723	olanzapine	Chemical	MESH:D000077152
16100469	Positive_Correlation	MESH:D000077152	MESH:D003693
16100469	Positive_Correlation	MESH:D008094	MESH:D004409
16100469	Positive_Correlation	MESH:D008094	MESH:D001480
16100469	Positive_Correlation	MESH:D000077152	MESH:D004409
16100469	Positive_Correlation	MESH:D008094	MESH:D003693
16100469	Cotreatment	MESH:D000077152	MESH:D008094
16100469	Positive_Correlation	MESH:D000077152	MESH:D001480

